Paxlovid and Molnupiravir Approved to Manage COVID-19: A Countdown for SARS CoV-2 Variant Apocalypse.

Résumé

I wish to recommend not to approve either Paxlovid or molnupiravir in those countries that are still considering their license, to revoke the emergency use authorization in those countries that issued it, and it is very unfortunate for humanity that safe, generic and highly effective Kelleni’s African protocol used to manage pediatric, adult and pregnant COVID-19 patients is not, yet, adopted by those countries where COVID-19 is wasting thousands of lives daily and I humbly suggest the reasons for this long-lasting ignorance are not medical or scientific.

Citer ce document

Accès au document

Ce document est hébergé sur son dépôt institutionnel d'origine.

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0